Miscellaneous urogenital disorders:
Indications for: KORSUVA
Moderate to severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis (HD).
Limitations of Use:
Not recommended for patients on peritoneal dialysis.
Give 0.5mcg/kg by IV bolus inj into the venous line of dialysis circuit at the end of each HD treatment. Administer within 60mins after completion of the syringe prep.
May impair mental or physical abilities. Increased somnolence in ≥65yrs. Severe hepatic impairment: not recommended. Pregnancy. Nursing.
Caution with concomitant centrally-acting depressant drugs, sedating antihistamines, opioid analgesics.
Diarrhea, dizziness, nausea, gait disturbances, falls, hyperkalemia, headache, somnolence, mental status change.
Generic Drug Availability:
Single-dose vial—1, 12